CureChat is a digital health company specializing in AI-driven solutions for chronic disease management. Its flagship product, Dana, is an AI-powered diabetes assistant that provides free, personalized, and medically accurate support based on ADA guidelines. CureChat focuses on improving diabetes education and accessibility, particularly in emerging markets, while ensuring privacy and compliance with healthcare standards.